Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Dexmedetomidine: Patients of this group will receive Inj Dexmedetomidine
0.25mcg per kg body weight in 100 ml saline over a period of 15 mins
intravenously before induction of anaesthes
Sponsors
Department of Anaesthesia School of medical sciences and research Sharda University
Eligibility
Inclusion criteria
Inclusion criteria: Patients scheduled for any elective surgery under general anaesthesia with endotracheal intubation ASA class I and II Age 18-60 years Both genders
Exclusion criteria
Exclusion criteria: Patients already taking steroids or analgesics or antiemetic and sedatives preoperatively for any clinical condition Patients with past history of chronic pain Patients having history of endocrine or cardiovascular or renal or CNS disease Patients allergic to study drugs Contraindication of succinylcholine for example High potassium level extensive burn renal failure or soft tissue injury BMI more than 30 kg meter square
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of Succinylcholine induced Postoperative Myalgia following intravenous administration of DexmedetomidineTimepoint: Perioperative | — |
Secondary
| Measure | Time frame |
|---|---|
| To observe and compare the grades of fasciculations and Postoperative Myalgia To compare the changes in the levels of serum potassium To find out the relationship between fasciculations and serum potassium levels and myalgia To compare the heart rate and systolic blood pressure in two groupsTimepoint: Perioperative | — |
Countries
India
Contacts
Public ContactDr Shivika Nath
School of Medical Sciences and Research Sharda hospital Sharda University
Outcome results
None listed